INVESTIGATIONAL DRUGS FOR
Volunteers & Patients
We empower study participants by educating them about clinical research, enabling them to make informed decisions regarding study participation.
NEW POSSIBILITIES FOR
Investigators
Clinilabs collaborates with investigator sites worldwide to conduct clinical trials that lead to new drug approvals. Become an investigator in our global network!
Experts in CNS Therapeutics
We specialize in a wide range of therapeutic areas with a focus on CNS studies conducted at investigator sites on five continents.
Sleep Disorders
Psychiatric Disorders
Neurological Disorders
New Treatments. New Possibilities.
The mid-sized CRO specializing in first-in-human to Phase 3 trials, with a global core laboratory.
Connect With Us
Connect with us online, or come visit us at
an upcoming industry event!
ASCP (Formerly NCDEU)
May 29 - June 1 at Loews Miami Beach HotelSLEEP Meeting Baltimore 2018
June 2 - June 6 at TBDAAIC 2018
July 22 - July 26 at McCormick Place
Latest News & Updates
Expansion of Regional Offices
Clinilabs Drug Development Corporation is pleased to announce that it has established two new regional offices in 2017. An office has been established in San Diego, California in order to accommodate the increasing number of [...]
Epilepsy Monitoring Unit
Clinilabs Drug Development Corporation is pleased to announce that it has established a 4-bed epilepsy monitoring unit at its New York City facility. The facility, which boasts a 50-bed inpatient capacity for clinical studies, offers [...]
CNS Sites of the Future
At this year’s CNS Summit, held in Boca Raton, Florida November 1 – 4 2017, attendees participated in a panel discussion that considered the characteristics that investigator sites will have in the future. Many of [...]